Spinal Disorders Perspective

 
 
  • How Should We Define Sacroiliitis? Dr Deane reviews a study that evaluated the Assessment of SpondyloArthritis international Society (ASAS) in a cohort of patients with persistent low back pain.
  • Bones and the Biome Medscape speaks with Dr Jose Scher about the connection between the human microbiota and rheumatologic disease.
  • Patients Weigh In on Biosimilars Medscape speaks with Seth Ginsberg, president and cofounder of the nonprofit Global Healthy Living Foundation about patient attitudes toward biosimilar medications.
  • Rheumatology Advances to Know From 2015 Dr Kevin Deane looks back at the biggest advances in rheumatology in 2015.
  • New Treatment Data for Inflammatory Arthritis   Drs Jonathan Kay and Ronald van Vollenhoven discuss new arthritis treatment findings presented at this year's American College of Rheumatology annual meeting.
  • An Important Consideration in Ankylosing Spondylitis   Dr Jonathan Kay talks about indication and treatment discrepancies on the ankylosing spondylitis spectrum, saying that some back pain patients end up excluded from some effective treatments.
  • Surgery for Your Lumbar Spinal Stenosis Patients? Maybe Not The largest study to date comparing the long-term outcomes of surgery vs nonsurgical treatment for patients with lumbar spinal stenosis found no significant difference in benefits after 8 years.
  • Joint Pain, Inflammation, and a Caribbean Vacation: A Case   Dr Paget discusses a recent patient of his who returned from a cruise in the Caribbean with severe joint pain and inflammation.
  • From Rome, the Latest in Rheumatology New findings in RA, OA, gout, and more, from the 2015 EULAR conference.
  • The Efficacy of Infliximab for Sarcoidosis In patients with severe sarcoidosis who do not respond to conventional therapies, could this anti-TNF agent provide symptom relief?
  • Central Lumbar Spinal Stenosis: Do Epidural Steroids Help? The benefits of epidural steroids for patients with central lumbar spinal stenosis are small at best, an expert asserts. Yet their use in Medicare patients has grown nearly 300% over a 7-year period.
  • Anxiety and Optimism on the Brink of Biosimilars Biosimilars are almost ready for prime time in the United States, but are healthcare professionals ready for them?
  • Comedication in Spondylitis and Anti-TNF Retention Dr Deane reviews and comments on a study evaluating the potential effect of comedication with conventional DMARDs on retention of anti-TNF agent use in spondylitis.
  • Doctors' Love/Hate Relationship With Second Opinions Despite a high incidence of misdiagnosis, some doctors take it personally when another doctor disagrees with their initial verdict or a patient goes elsewhere for treatment advice.
  • European League Against Rheumatism (EULAR) Congress 2015 Read clinically focused news coverage of key developments from EULAR 2015.
  • Whole-Body MRI to Detect Enthesitis Dr Deane discusses a study evaluating whole-body MRI to detect enthesitis in patients with psoriatic arthritis and axial spondyloarthritis.
  • When Families and Hospital Docs Disagree   In many hospital care situations, family members disagree with each other or with physicians over recommended treatment. What's an effective way to solve this problem?
  • Are Doctors Neglecting Their Older Patients? Whether or not older patients should get continued medical care has become a hot topic. Some of the issue rests on stereotypes about older people that doctors may hold.
  • Rheumatology Trends to Watch in 2015 Keep your eye on these steps forward taken in 2014 that could translate into patient care improvements in 2015.
  • Rheumatology Practice Changers 2014 A year's worth of advances in rheumatology, with the potential to change practice.